Cancer cells can be killed mechanically or with combinations of cytoskeletal inhibitors.

apoptosis cancer cytoskeleton mechanobiology mechanosensitivity transformed growth ultrasound

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 28 05 2022
accepted: 12 08 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

For over two centuries, clinicians have hypothesized that cancer developed preferentially at the sites of repeated damage, indicating that cancer is basically "continued healing." Tumor cells can develop over time into other more malignant types in different environments. Interestingly, indefinite growth correlates with the depletion of a modular, early rigidity sensor, whereas restoring these sensors in tumor cells blocks tumor growth on soft surfaces and metastases. Importantly, normal and tumor cells from many different tissues exhibit transformed growth without the early rigidity sensor. When sensors are restored in tumor cells by replenishing depleted mechanosensory proteins that are often cytoskeletal, cells revert to normal rigidity-dependent growth. Surprisingly, transformed growth cells are sensitive to mechanical stretching or ultrasound which will cause apoptosis of transformed growth cells (Mechanoptosis). Mechanoptosis is driven by calcium entry through mechanosensitive Piezo1 channels that activate a calcium-induced calpain response commonly found in tumor cells. Since tumor cells from many different tissues are in a transformed growth state that is, characterized by increased growth, an altered cytoskeleton and mechanoptosis, it is possible to inhibit growth of many different tumors by mechanical activity and potentially by cytoskeletal inhibitors.

Identifiants

pubmed: 36299893
doi: 10.3389/fphar.2022.955595
pii: 955595
pmc: PMC9589226
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

955595

Informations de copyright

Copyright © 2022 Tijore, Yang and Sheetz.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

PLoS One. 2009 Jul 23;4(7):e6361
pubmed: 19626122
Mol Biol Cell. 2016 Nov 7;27(22):3471-3479
pubmed: 27122603
EMBO J. 2021 Jan 15;40(2):e106123
pubmed: 33274785
Sci Rep. 2018 Nov 16;8(1):17226
pubmed: 30443010
Biochim Biophys Acta. 2013 Dec;1833(12):3124-3133
pubmed: 24021264
J Cell Sci. 2010 Feb 1;123(Pt 3):413-23
pubmed: 20067993
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5328-33
pubmed: 22431603
Phys Biol. 2011 Feb;8(1):015015
pubmed: 21301068
Oncol Rep. 2016 May;35(5):2499-515
pubmed: 26986034
EMBO J. 2010 Mar 17;29(6):1055-68
pubmed: 20150894
J Sport Health Sci. 2021 Mar;10(2):201-210
pubmed: 32738520
Nat Mater. 2020 Feb;19(2):239-250
pubmed: 31659296
J Cell Biol. 2013 Sep 30;202(7):1057-73
pubmed: 24081490
Sci Transl Med. 2018 Aug 8;10(453):
pubmed: 30089632
PLoS One. 2012;7(5):e36831
pubmed: 22662126
Nat Mater. 2017 Jul;16(7):775-781
pubmed: 28459445
Int J Mol Sci. 2020 Nov 20;21(22):
pubmed: 33233645
Biomed Pharmacother. 2018 Dec;108:1845-1855
pubmed: 30372890
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12817-12825
pubmed: 32444491
Science. 1977 Jul 29;197(4302):461-3
pubmed: 560061
Front Cell Dev Biol. 2022 Jul 19;10:959521
pubmed: 35927990
Annu Rev Physiol. 2019 Feb 10;81:585-605
pubmed: 30403543
Cell Biochem Biophys. 2021 Dec;79(4):757-767
pubmed: 33826035
Oncogene. 2005 Dec 15;24(56):8291-303
pubmed: 16170368
PLoS One. 2016 Oct 19;11(10):e0163915
pubmed: 27760153
Anticancer Res. 2010 Jun;30(6):2125-33
pubmed: 20651361
Chin J Physiol. 2014 Oct 31;57(5):256-64
pubmed: 25241985
Nat Cell Biol. 2016 Jan;18(1):33-42
pubmed: 26619148
Biomaterials. 2021 Aug;275:120866
pubmed: 34044258
Front Cell Dev Biol. 2021 Jan 12;8:607844
pubmed: 33585447
Epidemiol Rev. 2017 Jan 1;39(1):71-92
pubmed: 28453622
Cell Death Dis. 2019 Nov 4;10(11):837
pubmed: 31685811
New J Phys. 2013 Jan 18;15:015008
pubmed: 25110459
Cell Death Dis. 2018 Feb 28;9(3):334
pubmed: 29491433
Mol Med Rep. 2018 Mar;17(3):4237-4244
pubmed: 29328455
Chin J Physiol. 2019 May-Jun;62(3):123-130
pubmed: 31249266
Nano Lett. 2016 Sep 14;16(9):5951-61
pubmed: 27559755
Oncotarget. 2021 Jul 20;12(15):1470-1489
pubmed: 34316328
J Cell Physiol. 2021 Feb;236(2):1025-1042
pubmed: 32697363
Cancers (Basel). 2020 Jul 03;12(7):
pubmed: 32635333
Biochim Biophys Acta Mol Cell Res. 2019 Apr;1866(4):650-662
pubmed: 30668969
Mayo Clin Proc. 2014 Aug;89(8):1108-15
pubmed: 24958698
Biochem Biophys Res Commun. 2012 Jan 13;417(2):903-9
pubmed: 22209849
Sci Rep. 2022 Apr 15;12(1):6322
pubmed: 35428847
J Cell Biol. 1997 Apr 7;137(1):231-45
pubmed: 9105051
Biomaterials. 2015;53:274-84
pubmed: 25890726
Molecules. 2020 Dec 17;25(24):
pubmed: 33348838
Nat Phys. 2019 Jul;15(7):689-695
pubmed: 33790983
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Annu Rev Cell Dev Biol. 2019 Oct 6;35:169-190
pubmed: 31412209
Nano Lett. 2017 Dec 13;17(12):7242-7251
pubmed: 29052994
JAMA Intern Med. 2016 Jun 1;176(6):816-25
pubmed: 27183032
Cells. 2021 Oct 20;10(11):
pubmed: 34831037
Cell Mol Bioeng. 2015 Mar;8(1):76-85
pubmed: 25866589
PLoS One. 2014 Mar 14;9(3):e91656
pubmed: 24632809
Oncogene. 2003 Sep 18;22(40):6194-203
pubmed: 13679858
Bioeng Transl Med. 2021 Jun 11;6(3):e10233
pubmed: 34589605
Trends Biochem Sci. 2021 Oct;46(10):812-821
pubmed: 34088564
Front Bioeng Biotechnol. 2021 Jan 18;8:608526
pubmed: 33585411
Hum Exp Toxicol. 2014 Mar;33(3):270-83
pubmed: 23760257
Cancer Cell. 2003 Jun;3(6):537-49
pubmed: 12842083
J Natl Cancer Inst. 2015 Mar 16;107(5):
pubmed: 25780062
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165834
pubmed: 32437958
Cancer Cell. 2005 Sep;8(3):241-54
pubmed: 16169468
Breast Cancer Res Treat. 2009 Sep;117(1):131-40
pubmed: 18932017
Sci Rep. 2017 Jan 05;7:39975
pubmed: 28054593
Comput Struct Biotechnol J. 2018 Jul 27;16:279-287
pubmed: 30128085
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Oncol Lett. 2017 Dec;14(6):6929-6936
pubmed: 29151919
BMC Cancer. 2019 Jul 27;19(1):738
pubmed: 31351450

Auteurs

Ajay Tijore (A)

Centre for Biosystems Science and Engineering, Indian Institute of Science, Bangalore, India.

Bo Yang (B)

Mechanobiology Institute, National University of Singapore, Singapore, Singapore.

Michael Sheetz (M)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, United States.

Classifications MeSH